Glycyrrhizin therapy for viral infections | Zendy

Kei Numazaki | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Glycyrrhizin therapy for viral infections

Author(s) -

Kei Numazaki

Publication year - 2003

Publication title -

african journal of biotechnology

Language(s) - English

Resource type - Journals

ISSN - 1684-5315

DOI - 10.5897/ajb2003.000-1081

Subject(s) - glycyrrhizin , liver dysfunction , cytomegalovirus , medicine , respiratory system , urinary system , immunology , virology , gastroenterology , pharmacology , virus , viral disease , herpesviridae

Glycyrrhizin (GL) was reported as the most active in inhibiting replication of the severe acute respiratory syndrome (SARS)-associated coronavirus. Therapeutic effect of GL for liver dysfunction associated with cytomegalovirus (CMV) infection in immunocompetent individuals was evaluated. Liver dysfunction in 4 cases improved and CMV disappeared from urinary samples after administration of GL intravenously by the age of 12 months. GL treatment also should be applied for the patients with SARS. Key words : Glycyrrhizin, SARS, cytomegalovirus African Journal of Biotechnology Vol.2(10) 2003: 392-393

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research